GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Capital Expenditure

Cipher Pharmaceuticals (TSX:CPH) Capital Expenditure : C$-0.05 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Cipher Pharmaceuticals's cash flow for capital expenditures for the three months ended in Sep. 2024 was C$-0.03 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.05 Mil.

Cipher Pharmaceuticals Capital Expenditure Historical Data

The historical data trend for Cipher Pharmaceuticals's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Capital Expenditure Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.73 -0.97 - -0.11 -0.19

Cipher Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 -0.02 -0.03

Cipher Pharmaceuticals Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Capital Expenditure
Comparable Companies
TSX:ACB TSX:TSND XCNQ:CL TSX:OGI TSX:GUD XCNQ:GRIN TSX:CRDL TSX:WEED XCNQ:PLTH TSXV:RX ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
CPHRF:USA PHE:Germany
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Website
https://www.cipherpharma.com
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.
Executives
Christian Godin Director
Bryan Jacobs Senior Officer
Scott Langille Senior Officer
Nadine Jutlah Senior Officer
Arthur Marie Joseph Ghislain Deboeck Director
Mark Beaudet Director

Cipher Pharmaceuticals Headlines

No Headlines